Ravi Jhaveri, MD Disclosures: Consulting Fee-AstraZeneca|Consulting Fee-Seqirus|Consulting Fee-Dynavax|Royalties or Patent Beneficiary-UpToDate|Independent Contractor (included contracted research)-Elsevier (Relationship has ended)|Independent Contractor (included contracted research)-Pediatric Infectious Diseases Society|Grant or research support-GlaxoSmithKline - 10/11/2022 No Bio Available.